TLR-2 agonist Pam3CSK4 has no therapeutic effect on visceral leishmaniasis in BALB/c mice and may enhance the pathogenesis of the disease-Reference-Cited by-同舟云学术

TLR-2 agonist Pam3CSK4 has no therapeutic effect on visceral leishmaniasis in BALB/c mice and may enhance the pathogenesis of the disease

Published:2023-09 Issue:5 Volume:228 Page:152725
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Liao Xuechun^ORCID,He Jinlei^ORCID,Wang Ruanyan,Zhang Jianhui,Wei Shulan,Xiao Yuying,Zhou Qi,Zheng Xiaoting,Zhu Zheying^ORCID,Zheng Zhiwan,Li Jiao,Zeng Zheng,Chen Dali,Chen Jianping

Funder

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference60 articles.

1. Paradoxical immune response in leishmaniasis: The role of toll-like receptors in disease progression;Bamigbola;Parasite Immunol.,2022

2. Leishmania donovani-Induced Prostaglandin E2 Generation Is Critically Dependent on Host Toll-Like Receptor 2-Cytosolic Phospholipase A2 Signaling;Bhattacharjee;Infect. Immun.,2016

3. Arabinosylated lipoarabinomannan-mediated protection in visceral leishmaniasis through up-regulation of toll-like receptor 2 signaling: an immunoprophylactic approach;Bhattacharya;J. Infect. Dis.,2010

4. Porin of Shigella dysenteriae directly promotes toll-like receptor 2-mediated CD4+ T cell survival and effector function;Biswas;Mol. Immunol.,2009

5. Toll-dependent selection of microbial antigens for presentation by dendritic cells;Blander;Nature,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic profiling revealed immune-related signaling pathways in response to experimental infection of Leishmania donovani in two desert lizards from Northwest China;Developmental & Comparative Immunology;2024-07

2. LdCyPA attenuates MAPK pathway to assist Leishmania donovani immune escape in host cells;Acta Tropica;2024-03